CN100335056C - 一种药物组合物及其在制备治疗ⅱ型糖尿病药物中的应用 - Google Patents
一种药物组合物及其在制备治疗ⅱ型糖尿病药物中的应用 Download PDFInfo
- Publication number
- CN100335056C CN100335056C CNB2004100723312A CN200410072331A CN100335056C CN 100335056 C CN100335056 C CN 100335056C CN B2004100723312 A CNB2004100723312 A CN B2004100723312A CN 200410072331 A CN200410072331 A CN 200410072331A CN 100335056 C CN100335056 C CN 100335056C
- Authority
- CN
- China
- Prior art keywords
- taurine
- gliquidone
- diabetes
- treatment
- consumption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
组别 | 例数 | 年龄 | 糖尿病病程(年) | 尿蛋白(g/L) | BUN(mmol/L) | HbAlc(%) |
对照组 | 8 | 54±6.7 | 10.3±7.1 | 6.2±2.5 | 9.5±0.7 | 6.5±1.2 |
治疗组 | 10 | 57±6.6 | 12.4±5.9 | 6.9±2.8 | 9.2±0.3 | 6.4±1.3 |
组别 | 例数 | 空腹血糖(FBG) | 餐后2小时血糖 | ||||||
显效 | 有效 | 无效 | 总有效率 | 显效 | 有效 | 无效 | 总有效率 | ||
对照 | 10 | 3 | 6 | 1 | 90.0 | 4 | 6 | 0 | 100.0 |
治疗 | 12 | 5 | 7 | 0 | 100.0 | 7 | 5 | 0 | 100.0 |
组别 | 空腹血糖(FBG) | 餐后2小时血糖 | ||||||||
治疗前 | 治疗后 | 治疗前 | 治疗后 | |||||||
2周 | 4周 | 8周 | 12周 | 2周 | 4周 | 8周 | 12周 | |||
对照 | 10.72 | 9.99 | 9.27 | 8.43 | 7.62 | 14.79 | 13.48 | 12.77 | 10.07 | 9.21 |
治疗 | 10.68 | 9.76 | 9.05 | 8.12 | 7.26 | 14.88 | 13.24 | 12.35 | 9.57 | 7.66* |
组别 | 例数 | 尿蛋白(g/L) | BUN(mmol/L) | Scr(μmol/L) | |
对照组 | 8 | 治疗前 | 6.2±2.5 | 9.5±0.7 | 251.3±54.6 |
治疗后 | 6.0±2.7 | 9.2±0.6 | 250.9±49.3 | ||
治疗组 | 10 | 治疗前 | 6.9±2.8 | 9.2±0.3 | 248.2±56.1 |
治疗后 | 5.8±2.1* | 7.3±0.5* | 153.4±47.5* |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100723312A CN100335056C (zh) | 2004-10-18 | 2004-10-18 | 一种药物组合物及其在制备治疗ⅱ型糖尿病药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100723312A CN100335056C (zh) | 2004-10-18 | 2004-10-18 | 一种药物组合物及其在制备治疗ⅱ型糖尿病药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1762356A CN1762356A (zh) | 2006-04-26 |
CN100335056C true CN100335056C (zh) | 2007-09-05 |
Family
ID=36746814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100723312A Expired - Fee Related CN100335056C (zh) | 2004-10-18 | 2004-10-18 | 一种药物组合物及其在制备治疗ⅱ型糖尿病药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100335056C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111960972B (zh) * | 2020-08-28 | 2023-04-18 | 许昌远志生物科技有限公司 | 牛磺酸镁盐及牛磺酸镁配合物的制备工艺与应用 |
-
2004
- 2004-10-18 CN CNB2004100723312A patent/CN100335056C/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
口服抗糖尿病药物的临床应用 曹秀虹等,Chinese Genenral Practice 2002,Vol.5 No.5 2002 * |
Also Published As
Publication number | Publication date |
---|---|
CN1762356A (zh) | 2006-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2623023C2 (ru) | Ликсисенатид и метформин для лечения диабета типа 2 | |
CN1686547A (zh) | 长期使用的治疗糖尿病的复方制剂 | |
CA2907079C (en) | Combination of canagliflozin and probenecid for the treatment of hyperuricemia | |
CN101897696A (zh) | 降糖药物组合物及其用途 | |
CN105473155A (zh) | 甘精胰岛素/利西拉来固定比率配制剂 | |
CN110420315A (zh) | 枸杞糖肽在制备治疗三高药物中的应用 | |
CZ295567B6 (cs) | Tetrahydrolipstatin pro výrobu orálního farmaceutického prostředku pro ošetřování typu II diabetes mellitus | |
WO2005049006A1 (ja) | 糖尿病治療剤 | |
RU2451506C1 (ru) | Комбинация для лечения сахарного диабета и его осложнений | |
RU2694527C1 (ru) | Комбинация для регенеративной терапии больных сахарным диабетом 1 типа | |
US6492339B1 (en) | Compositions comprising D-chiro inositol and sulfonylureas and methods of treatment thereof | |
WO2005092349A1 (ja) | インスリン抵抗性改善剤 | |
CN100335056C (zh) | 一种药物组合物及其在制备治疗ⅱ型糖尿病药物中的应用 | |
CA3091729A1 (en) | Glp-1 composition for treating obesity and weight management | |
CN101757627A (zh) | 用于治疗糖尿病的联合用药及药物组合物 | |
KR20070086137A (ko) | FBPase 저해제를 함유하는 의약 조성물 | |
CN1823795A (zh) | 一种治疗糖尿病的药物组合物及其制备方法 | |
US6486127B1 (en) | Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof | |
CN101897698A (zh) | 含有维格列汀和b族维生素的降糖药物组合物及其用途 | |
CN101537102A (zh) | 一种治疗糖尿病的药食两用组合物及其制备方法 | |
CN1636581A (zh) | 一种红花药物组合物、其制备方法及其用途 | |
CA3104916A1 (en) | Pharmaceutical composition for preventing diabetes and use thereof | |
CN1070069C (zh) | 治疗糖尿病的组合药物 | |
CN106880643A (zh) | 用于治疗糖尿病的联合用药及药物组合物 | |
CN101444507A (zh) | 一种治疗ⅱ型糖尿病的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN TAIPU MEDICAL INTELLECTUAL PROPERTY CIRCUL Free format text: FORMER OWNER: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Effective date: 20120110 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120110 Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee after: Tianjin Taipu Pharmaceutical Intellectual Property Flow Reserve Center Co, Ltd. Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Institute of Pharmaceutical Research |
|
ASS | Succession or assignment of patent right |
Owner name: TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Free format text: FORMER OWNER: TIANJIN TAIPU PHARMACEUTICAL INTELLECTUAL PROPERTY TRANSFER RESERVE CENTER CO., LTD. Effective date: 20140505 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140505 Address after: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee after: Tianjin Institute of Pharmaceutical Research Address before: 300193 Tianjin City, Nankai District Anshan West Road No. 308 Patentee before: Tianjin Taipu Pharmaceutical Intellectual Property Flow Reserve Center Co, Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070905 Termination date: 20151018 |
|
EXPY | Termination of patent right or utility model |